Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
127996421 | 12799642 | 1 | I | 20160727 | 20160923 | 20160930 | 20160930 | EXP | GB-MHRA-TPP24080327C1860021YC1469606037611 | GB-MYLANLABS-2016M1041280 | MYLAN | 0.00 | Y | 0.00000 | 20160930 | MD | GB | GB |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
127996421 | 12799642 | 1 | PS | INDAPAMIDE. | INDAPAMIDE | 1 | Oral | 2.5 MG, UNK | Y | U | 74461 | 2.5 | MG | ||||||
127996421 | 12799642 | 2 | C | AMITRIPTYLINE HYDROCHLORIDE. | AMITRIPTYLINE HYDROCHLORIDE | 1 | 50 MG, QD (AT NIGHT.) | 1800 | MG | U | 0 | 50 | MG | QD | |||||
127996421 | 12799642 | 3 | C | AMLODIPINE | AMLODIPINE BESYLATE | 1 | 1 DF, QD | 41 | DF | U | 0 | 1 | DF | QD | |||||
127996421 | 12799642 | 4 | C | ATORVASTATIN | ATORVASTATIN | 1 | 1 DF, QD (AT NIGHT) | 36 | DF | U | 0 | 1 | DF | QD | |||||
127996421 | 12799642 | 5 | C | DOCUSATE SODIUM. | DOCUSATE SODIUM | 1 | 2 DF, UNK (TWICE DAILY.) | U | 0 | 2 | DF | TABLET | |||||||
127996421 | 12799642 | 6 | C | FERROUS SULFATE. | FERROUS SULFATE | 1 | 1 DF, QD | 36 | DF | U | 0 | 1 | DF | QD | |||||
127996421 | 12799642 | 7 | C | FLUTICASONE | FLUTICASONEFLUTICASONE PROPIONATE | 1 | Respiratory (inhalation) | 2 DF, BID | 144 | DF | U | 0 | 2 | DF | BID | ||||
127996421 | 12799642 | 8 | C | LACTULOSE. | LACTULOSE | 1 | 15 ML, UNK (TWICE DAILY.) | U | 0 | 15 | ML | ||||||||
127996421 | 12799642 | 9 | C | LEVOTHYROXINE. | LEVOTHYROXINE | 1 | 100 ?G, QD (EACH MORNING.) | 3600 | UG | U | 0 | 100 | UG | QD | |||||
127996421 | 12799642 | 10 | C | PARACETAMOL | ACETAMINOPHEN | 1 | TAKE 1 OR 2, 4 TIMES A DAY. | U | 0 | TABLET | |||||||||
127996421 | 12799642 | 11 | C | PREGABALIN. | PREGABALIN | 1 | 250 MG, BID (100 MG IN THE MORNING AND 150 MG AT NIGHT) | 18000 | MG | U | 0 | 250 | MG | BID | |||||
127996421 | 12799642 | 12 | C | RAMIPRIL. | RAMIPRIL | 1 | 10 MG, QD (IN THE EVENING) | 360 | MG | U | 0 | 10 | MG | QD | |||||
127996421 | 12799642 | 13 | C | SALBUTAMOL | ALBUTEROL | 1 | Respiratory (inhalation) | 2 DF, UNK | U | 0 | 2 | DF | |||||||
127996421 | 12799642 | 14 | C | SERETIDE | FLUTICASONE PROPIONATESALMETEROL XINAFOATE | 1 | Respiratory (inhalation) | UNK | U | 0 |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
127996421 | 12799642 | 5 | Constipation |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
127996421 | 12799642 | OT |
127996421 | 12799642 | LT |
127996421 | 12799642 | HO |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
127996421 | 12799642 | Confusional state | |
127996421 | 12799642 | Hyponatraemia |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
127996421 | 12799642 | 1 | 20160727 | 0 | ||
127996421 | 12799642 | 2 | 20160621 | 0 | ||
127996421 | 12799642 | 3 | 20160616 | 0 | ||
127996421 | 12799642 | 4 | 20160621 | 0 | ||
127996421 | 12799642 | 5 | 20160621 | 0 | ||
127996421 | 12799642 | 6 | 20160621 | 0 | ||
127996421 | 12799642 | 7 | 20160621 | 0 | ||
127996421 | 12799642 | 8 | 20160621 | 0 | ||
127996421 | 12799642 | 9 | 20160621 | 0 | ||
127996421 | 12799642 | 10 | 20160621 | 0 | ||
127996421 | 12799642 | 11 | 20160621 | 0 | ||
127996421 | 12799642 | 12 | 20160621 | 0 | ||
127996421 | 12799642 | 13 | 20160621 | 0 |